Tyron, J. M.
Bluhm, R.
Achtyes, E. D. http://orcid.org/0000-0001-8939-1535
McCright, A. M. http://orcid.org/0000-0001-6251-5251
Cabrera, L. Y. http://orcid.org/0000-0002-6220-7096
Funding for this research was provided by:
National Institutes of Health (RF1MH117802, RF1MH117802, RF1MH117802, RF1MH117802)
Article History
Received: 21 January 2023
Accepted: 18 April 2023
First Online: 3 May 2023
Competing interests
: J.T., R.B., and A.M. declare no competing financial or non-financial interests. E.A. declares the following competing financial and non-financial interests; he has served on advisory boards for Karuna, Alkermes, Janssen, Lundbeck/Otsuka, Roche, Sunovion, and Teva. E.A. has received research support from Alkermes, Astellas, Biogen, Boehringer-Ingelheim, InnateVR, Janssen, National Network of Depression Centers, Neurocrine Biosciences, Novartis, Otsuka, Pear Therapeutics, Takeda and serves on the SMI Adviser LAI Center of Excellence (unpaid). L.C. declares the following competing financial and non-financial interests; she has received research support from the National Network of Depression Centers and serves on the Board of Directors for the International Neuroethics Society (unpaid) as well as on the Advisory Council for the Institute of Neuroethics (unpaid).